by | May 21, 2025 | Lupus Foundation of America
In a new study, researchers identified eight disease activity domains for further development into the new Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE), a clinical trial outcome assessment (COA) for systemic lupus erythematosus (SLE)...
by | May 21, 2025 | Lupus Foundation of America, News & Events
A new study found higher serum levels, specifically S100A8/A9, and not significantly MMP-9, in the blood, are associated with cognitive impairment (CI) in those with Systemic Lupus Erythematous. S100A8/A9 is a protein complex found in the blood that’s secreted by...
by | May 21, 2025 | Lupus Foundation of America, News & Events
A new study found higher serum levels, specifically S100A8/A9, and not significantly MMP-9, in the blood, are associated with cognitive impairment (CI) in those with Systemic Lupus Erythematous. S100A8/A9 is a protein complex found in the blood that’s secreted by...
by | May 14, 2025 | Lupus Foundation of America, News & Events
This week, the American College of Rheumatology (ACR) released updated guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. The new guidelines aim to reach and preserve remission or low disease activity,...
by | May 12, 2025 | Lupus Foundation of America, News & Events
The American College of Rheumatology (ACR) recently released updated guidelines for the screening, treatment and management of lupus nephritis (LN), lupus-related kidney disease, to offer best practices for clinicians and individuals with LN. This full publication of...
by | May 11, 2025 | Lupus Foundation of America
Having been diagnosed with lupus over 20 years ago, Kristine Falk occasionally had to call in sick to work due to her lupus symptoms. But on a fall day in 2011, she was off work for a different reason: to support her daughter, Kaz Brown, who was a sophomore playing in...
